YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$107,498 | $684,731 | $963,129 | $1,029,495 |
| Dep. & Amort. | -$7,801,515 | $8,197,175 | $198,367 | $192,907 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $89,971 | $0 | $45,136 | $0 |
| Change in WC | -$826,352 | $0 | -$1,511,930 | $0 |
| Other Non-Cash | $8,710,407 | -$8,857,501 | $733,711 | $22,397 |
| Operating Cash Flow | $65,013 | $24,405 | $428,413 | $1,244,799 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$566,411 | -$401,892 | -$128,132 | -$215,586 |
| Net Acquisitions | -$12,600 | $0 | $0 | $0 |
| Inv. Purchases | -$2,760,105 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $2,763,105 | $0 | $0 | $0 |
| Other Inv. Act. | $513,718 | $552,446 | -$535,101 | $1,433,387 |
| Investing Cash Flow | -$62,293 | $150,554 | -$663,233 | $1,217,801 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$188,048 | -$275,091 | $0 | $481,402 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $65,988 | -$51,162 | -$1,872,389 | -$85,912 |
| Financing Cash Flow | -$122,060 | -$326,253 | -$1,872,389 | $395,490 |
| Forex Effect | -$3 | $1 | $13 | -$24 |
| Net Chg. in Cash | -$119,343 | $1,523,120 | $0 | $2,858,066 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,523,120 | $0 | $3,781,609 | $923,543 |
| End Cash | $1,403,777 | $1,523,120 | $3,781,609 | $3,781,609 |
| Free Cash Flow | -$715,198 | -$377,487 | $300,281 | $1,029,213 |